High quality and stable liposomes Research and Development Department of Company W, a cosmetics manufacturer

Win product competitions with liposomes

New liposome method yields 200 trillion per mL

Life Sciences
Durability/stability

Solutions

Solution Summary

  • The liposome "ILINPSOME," jointly developed by Nippon Shokubai and Lilac Pharma, is of high quality and stability.

  • There is no need to add thickeners, and it can be stored at room temperature for over a year, reducing refrigeration costs.

  • Approximately 200 trillion liposomes are present in 1 mL, providing high permeability.

ILINPSOME, made using a new manufacturing method, achieves high stability and overcomes the challenges of conventional liposomes!

At that time, one of the members came across a news release about a liposome called "ILINPSOME" that Nippon Shokubai had jointly developed with Lilac Pharma.
Mr. K immediately contacted Nippon Shokubai, and after being introduced to the product by a representative, he immediately realized that this new liposome had great potential.

ILINPSOME is a high-quality liposome made using a new manufacturing method developed by Lilac Pharma, a venture company spun off from Hokkaido University, using the microfluidic device "iLiNP™" technology licensed from the university. This method achieves high liposome stability and eliminates the need for thickeners. It can be stored at room temperature for over a year, and retains the texture of natural liposomes.

"There are approximately 200 trillion liposomes in 1 mL of ILINPSOME, and because the structure is stable, it is able to demonstrate the high permeability inherent to liposomes," says Mr. K.

We immediately received a sample of ILINPSOME from Nippon Shokubai and decided to evaluate it as a skin care serum. As a result, we were able to create a prototype of a revolutionary skin care serum that was rich and moisturizing.
Mr. K felt very positive about this result and decided to join Team B in an internal competition with a project that put ILINPSOME at the forefront.

As a result, Team B won the in-house competition and was selected to commercialize a skin care serum using ILINPSOME.
Mr. K and Team B have now officially launched a development project, and are working with Nippon Shokubai to commercialize a liposome-containing skin care serum.

Explore the Solution

1 2